Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Hexagon Nutrition Ltd (HEXAGON) Share Price & Fundamentals

Company Overview

Founded Year

1993

Listed Year

2022

Headquarter

Mumbai, Maharashtra, India

MD/CEO

Arun Purushottam Kelkar

Website

https://hexagonnutrition.com

Company Facts

What we do

Hexagon Nutrition Ltd is a research-driven pure-play nutrition company specializing in nutraceuticals, micronutrient premixes, clinical nutrition, and therapeutic foods.

Founded in

1,993

Market share

Largest premix player in India; top ten globally with strong brand presence in clinical and wellness nutrition.

Problem solved

Addresses malnutrition, clinical nutrition needs, and food fortification to enhance health across all age groups.

Top clients or who we serve

B2B clients include multinational FMCG companies; B2C through branded products; exports to ~70 countries.

Key management

Arun Purushottam Kelkar (Chairman & Executive Director), Vikram Arun Kelkar (Managing Director), Dr. Nikhil Arun Kelkar (Joint Managing Director).

Our journey and innovations

Started in 1993; expanded manufacturing; introduced brands Pentasure, Obesigo, and Pediagold; established food testing lab; R&D focused on novel nutrient formulations.

Where we operate

India and exports to nearly 70 countries including South Africa, Malaysia, Ethiopia, France, and more.

Top products or what we offer

Branded clinical nutrition (Pentasure, Obesigo, Pediagold), premix formulations for FMCG, ready-to-use therapeutic foods and micronutrient powders.

Top brands

Pentasure - adult wellness & clinical nutrition; Obesigo - weight management; Pediagold - pediatric nutrition; leading premix products serving FMCG giants.

Raw materials needed

Vitamins, minerals, whey protein and other micronutrients for premixes and therapeutic foods.

Raw materials supplier

Suppliers vary locally and internationally, ensuring quality and compliance standards.

Recurring vs cyclical contribution

Mix of recurring B2B premix contracts and cyclical B2C branded product sales.

Our industry position

Market leader in premixes in India and significant global player, strong portfolio across nutrition segments.

Financial highlights

FY22 consolidated revenue Rs. 2709 million; net profit Rs. 233 million; standalone revenue Rs. 1067 million; growing profitability.

Geographical revenue split

India contributes Rs. 126 crore; Rest of World Rs. 199 crore approx.

Order book

-

Whats driving growth

Rising health awareness, global malnutrition initiatives, strong R&D, and geographic expansion.

Our future plans

IPO for expansion, increasing manufacturing capacity (new Uzbekistan facility), global market growth.

Our green promise

-

Our people and values

100+ sales force; focus on diversity; culture of innovation and compliance.

Key challenges ahead

Competition in nutrition space, regulatory compliance, and supply chain management.

Interesting facts

First in India to offer integrated nutritional premix and therapeutic product portfolio with patented whey formulations.

Risks and strategy

Focused risk management; diversify product portfolio; strengthen international presence with regulatory compliance.

Market Footprint

Top Clients

Top Clients

B2B clients include multinational FMCG companies; B2C through branded products; exports to ~70 countries.

Top Products

Top Products

Branded clinical nutrition (Pentasure, Obesigo, Pediagold), premix formulations for FMCG, ready-to-use therapeutic foods and micronutrient powders.

Price Movement & Share Holding

Today's High/Low

56.458.49

52 Week High/Low

48.178.25
Past Returns

1 week

-12.26%

1 month

-17.45%

3 month

-17.45%

1 year

-17.45%

3 year

-17.45%

5 year

-17.45%

Share Holding

Promoters

64.36%

FII

0.29%

DII

4.12%

Retail

27.28%

Others

3.96%

Company Overview

Founded Year

1993

Listed Year

2022

Headquarter

Mumbai, Maharashtra, India

MD/CEO

Arun Purushottam Kelkar (Chairman & Executive Director)

Website

https://hexagonnutrition.com

Price Movement & Share Holding

Today's High/Low

56.458.49

52 Week High/Low

48.178.25

Past Returns

1 week

-12.26%

1 month

-17.45%

3 month

-17.45%

1 year

-17.45%

3 year

-17.45%

5 year

-17.45%

Share Holding

Promoters

64.36%

FII

0.29%

DII

4.12%

Retail

27.28%

Others

3.96%

Company Facts

What we do

Hexagon Nutrition Ltd is a research-driven pure-play nutrition company specializing in nutraceuticals, micronutrient premixes, clinical nutrition, and therapeutic foods.

Founded in

1993

Market share

Largest premix player in India; top ten globally with strong brand presence in clinical and wellness nutrition.

Problem solved

Addresses malnutrition, clinical nutrition needs, and food fortification to enhance health across all age groups.

Top clients or who we serve

B2B clients include multinational FMCG companies; B2C through branded products; exports to ~70 countries.

Key management

Arun Purushottam Kelkar (Chairman & Executive Director), Vikram Arun Kelkar (Managing Director), Dr. Nikhil Arun Kelkar (Joint Managing Director).

Our journey and innovations

Started in 1993; expanded manufacturing; introduced brands Pentasure, Obesigo, and Pediagold; established food testing lab; R&D focused on novel nutrient formulations.

Where we operate

India and exports to nearly 70 countries including South Africa, Malaysia, Ethiopia, France, and more.

Top products or what we offer

Branded clinical nutrition (Pentasure, Obesigo, Pediagold), premix formulations for FMCG, ready-to-use therapeutic foods and micronutrient powders.

Top brands

Pentasure - adult wellness & clinical nutrition; Obesigo - weight management; Pediagold - pediatric nutrition; leading premix products serving FMCG giants.

Raw materials needed

Vitamins, minerals, whey protein and other micronutrients for premixes and therapeutic foods.

Raw materials supplier

Suppliers vary locally and internationally, ensuring quality and compliance standards.

Recurring vs cyclical contribution

Mix of recurring B2B premix contracts and cyclical B2C branded product sales.

Our industry position

Market leader in premixes in India and significant global player, strong portfolio across nutrition segments.

Financial highlights

FY22 consolidated revenue Rs. 2709 million; net profit Rs. 233 million; standalone revenue Rs. 1067 million; growing profitability.

Geographical revenue split

India contributes Rs. 126 crore; Rest of World Rs. 199 crore approx.

Whats driving growth

Rising health awareness, global malnutrition initiatives, strong R&D, and geographic expansion.

Our future plans

IPO for expansion, increasing manufacturing capacity (new Uzbekistan facility), global market growth.

Our people and values

100+ sales force; focus on diversity; culture of innovation and compliance.

Key challenges ahead

Competition in nutrition space, regulatory compliance, and supply chain management.

Interesting facts

First in India to offer integrated nutritional premix and therapeutic product portfolio with patented whey formulations.

Risks and strategy

Focused risk management; diversify product portfolio; strengthen international presence with regulatory compliance.

Market Footprint

Top Clients

Top Clients

B2B clients include multinational FMCG companies; B2C through branded products; exports to ~70 countries.

Top Products

Top Products

Branded clinical nutrition (Pentasure, Obesigo, Pediagold), premix formulations for FMCG, ready-to-use therapeutic foods and micronutrient powders.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions